Exclusive interview with Pfizer CEO Albert Bourla as the company files for emergency use authorization for its COVID-19 ...
The pharma company had to scale vaccine production from 200 million annually to 3 billion at the pandemic's peak.
Also: All the news and watercooler chat from Fortune.
Pharmaceutical giant Pfizer (PFE) released its fourth quarter earnings results that topped Wall Street's expectations on its ...
Albert Bourla admitted to going to extreme lengths to “save the world” and get the vaccines out faster during the COVID-19 ...
Pfizer CEO Albert Bourla said that the main thing getting in the way of changing vaccine discussions in the U.S. is the ...
13d
Pfizer CEO Calls RFK's Vaccine Views Anti-Science, Warns US Falling Behind China In Health Research
Pfizer CEO Albert Bourla criticizes RFK's vaccine stance, warns US health research is losing ground to China, and urges ...
Fox Business on MSN
Pfizer CEO addresses growing competition in weight-loss drugs
Pfizer CEO Albert Bourla discusses Pfizer’s Q4 adjusted earnings and the competitive landscape for weight-loss drugs on ‘The ...
SAN FRANCISCO, Jan 12 (Reuters) - Pfizer (PFE.N), opens new tab is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched erectile dysfunction drug ...
We recently published 12 Stocks on Jim Cramer’s Radar. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer’s radar. Pfizer Inc. (NYSE:PFE)’s shares are down by 5.90% year-to-date, and December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results